Herantis Pharma Oyj Long-term Investment Intensity
Herantis Pharma Oyj long-term investment intensity. Herantis Pharma Oyj (HRTIS) has a Long-term Investment Intensity of 0.0% as of June 2018. Long-term investments of €1.16K represent 0.0% of total assets of €9.42 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read HRTIS current and long-term liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Herantis Pharma Oyj (2014–2017)
Long-term investment intensity of Herantis Pharma Oyj from 2014 to 2017. This chart shows how Herantis Pharma Oyj's Long-term Investment Intensity has evolved across 4 annual periods from 2014 to 2017. As of June 2018, the intensity stands at 0.0%, reflecting long-term investments of €1.16K against total assets of €9.42 Million EUR.
Herantis Pharma Oyj Long-term Investment Intensity by Year (2014–2017)
Herantis Pharma Oyj long-term investment intensity by year from 2014 to 2017. The table below presents the year-by-year Long-term Investment Intensity for Herantis Pharma Oyj from 2014 to 2017, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Herantis Pharma Oyj.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 0.0% | €1.16K | €11.57 Million | ▼ 0.0 pp |
| 2016 | 0.0% | €1.16K | €10.21 Million | ▲ +0.0 pp |
| 2015 | 0.0% | €1.16K | €14.09 Million | ▲ +0.0 pp |
| 2014 | 0.0% | €1.16K | €29.49 Million | — |